SACRAMENTO, Calif. [March 17, 2009] – CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, which is focused on marketing its ROBODOC® Surgical System, announced today that they received the NSAI (National Standards of Ireland) Certificate of Registration of Quality Management System to I.S. EN ISO 13485:2003.

CUREXO Technology Company has been assessed and deemed to comply with the provisions of the above standard in respect to scope of operations to the design, manufacture, distribution and service of the pre-operative workstation and robotic surgical system and related accessories for revision and/or replacement arthroplasty.

"We are pleased to receive the NSAI certificate which validates that CUREXO’s quality system meets European requirements," stated Brent Mittelstadt, President and CEO of CUREXO Technology Corporation. "This regulatory milestone brings us one step closer to further expanding our global marketing strategy by entering emerging markets in countries such as Europe, New Zealand and Australia," Mr. Mittelstadt continued.

About CUREXO Technology Corporation
CUREXO Technology Corporation, develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. The ROBODOC® Surgical System includes two components; ORTHODOC®, a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC® Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee replacement surgeries.

The ROBODOC® Surgical System has been cleared by the U.S. FDA for Total Hip Arthroplasty procedures; making it the only active robotic system cleared by the FDA for orthopedic surgery. To date the system has been used in over 24,000 surgical procedures worldwide.

ROBODOC® , ORTHODOC® , and DigiMatch™ are registered trademarks of CUREXO Technology Corporation. For more information, visit www.robodoc.com.

About NSAI
For over 50 years, the National Standards Authority of Ireland has been offering a full range of services relating to Management Systems Standards and Certification Services throughout the world. The company specializes in medical device, aerospace and environmental certifications. For more information visit www.NSAIinc.com or call 603-882-4412.

SACRAMENTO, Calif. [March 2, 2009] – CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, which is focused on marketing its ROBODOC® Surgical System, announced today that it would be relocating its headquarters from Sacramento to Fremont and has already begun the transition with the corporate executives; the remainder of the company will be in place by April 2009.

CUREXO Technology Corporation’s new headquarters will be approximately 34,000 square feet which is more than 3 times the size of its current facility in Sacramento. This new location in the Silicon Valley provides excellent access to multiple international airports increasing headquarter accessibility to visitors. Fremont is located in the San Francisco East Bay area, just 15 miles from San Jose and 30 miles from Oakland.

"We are excited about moving the company to our new home,” stated Brent D. Mittelstadt, President and CEO of CUREXO Technology Corporation. The size of the new facility will allow CUREXO to fully embark on its U.S. launch and worldwide marketing strategy as it will provide ample space to manufacture our robotic system at a higher rate. As well, the location is strategic, as we will be physically closer to our vendors and we will be able to draw from a pool of highly accomplished professionals from the Silicon Valley that will complement our existing team of talented personnel,” continued Mr. Mittelstadt.

About CUREXO Technology Corporation CUREXO Technology Corporation develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. The ROBODOC® Surgical System includes two components; ORTHODOC®, a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC® Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee replacement surgeries. The ROBODOC® Surgical System has been cleared by the U.S. FDA for Total Hip Arthroplasty procedures; making it the only active robotic system cleared by the FDA for orthopaedic surgery. To date the system has been used in over 24,000 surgical procedures worldwide.

ROBODOC® and ORTHODOC® are registered trademarks of CUREXO Technology Corporation. For more information, visit www.robodoc.com.

SACRAMENTO, Calif. [February 25, 2009] – SACRAMENTO, Calif. [February 25, 2009] – CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, which is focused on marketing its robotic system, announced today that it has submitted a premarket notification 510(k) application to the U.S. Food and Drug Administration (FDA) for market clearance in the U.S. for use of its ROBODOC® Surgical System for Total Knee Arthroplasty (TKA).

The 510(k) application is used when there exist similar, previously-cleared technologies in the marketplace. This submission follows the company’s recently cleared 510(k) for Total Hip Arthroplasty (THA) and will offer surgeons an accurate, precise, and reproducible surgical technique to prepare the joint during a knee replacement procedure. The process will allow surgeons to preoperatively plan their surgery in a 3-D virtual space and then execute the surgery exactly as planned in the operating theatre.

"We are very pleased to announce the submission of the TKA 510(k) application to the FDA, as it demonstrates that we are moving forward with achieving our goals of providing a world class multi-platform technology,” said Brent D. Mittelstadt, President and CEO of CUREXO Technology Corporation. "We believe that because of our recent hip application clearance, receiving the TKA market clearance should be granted within a reasonable time frame. Offering this additional application will allow us to build upon relationships that we are establishing as we introduce the ROBODOC® Surgical System into the U.S. orthopaedic community,” continued Mr. Mittelstadt.

About CUREXO Technology Corporation

CUREXO Technology Corporation develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. The ROBODOC® Surgical System includes two components; ORTHODOC®, a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC® Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee replacement surgeries.

The ROBODOC® Surgical System has been cleared by the U.S. FDA for Total Hip Arthroplasty procedures; making it the only active robotic system cleared by the FDA for orthopaedic surgery. To date the system has been used in over 24,000 surgical procedures worldwide.

ROBODOC® and ORTHODOC® are registered trademarks of CUREXO Technology Corporation. For more information,
visit www.robodoc.com.

SACRAMENTO, Calif. [February 23, 2009] – CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, which is focused on marketing its ROBODOC® Surgical System, announced today that they will be exhibiting at the upcoming American Association of Orthopaedic Surgeons Annual Conference at the Sands Expo Center in Las Vegas, February 25th through the 27th, Booth #3456.

For the first time, ROBODOC® will display its accuracy through active demonstrations of hip and knee* replacement surgeries. In addition, Dr. William Bargar, Assistant Clinical Professor, Department of Orthopedic Surgery, University of California Davis School of Medicine will be sharing his clinical experiences using the system. The System provides consistent, reproducible outcomes, is the next generation beyond haptic systems, and has the only open platform providing surgeons with a choice of implants from the major implant manufacturers.

“I am very pleased to share my experience using ROBODOC with interested surgeons at the AAOS,” stated Dr. William Bargar. “The ROBODOC system allows surgeons to be very accurate. By preoperatively planning and being able to execute what you plan, you can now address issues such as implant fit and sizing, as well as off-set and leg length which are very important in terms of how the hip functions. The system allows you to not only plan the surgery better, but more importantly, you can execute the plan with sub-millimeter accuracy,” continued Dr. Bargar.

“We are looking forward to launching our robotics technology at the AAOS meeting in Las Vegas where we will present the only active robotic system cleared by the FDA for orthopaedic surgery,” stated Brent D. Mittelstadt, President and CEO of CUREXO Technology Corporation. “While the System has been in use for many years having completed more than 24,000 surgeries around the world, now with our recent FDA clearance for Total Hip Arthroplasty (THA) we can offer our products to U.S. surgeons. In addition, we are further developing strong technical and marketing initiatives, and are prepared to move forward into the U.S. Market,” added Mr. Mittelstadt.

About CUREXO Technology Corporation

CUREXO Technology Corporation develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. The ROBODOC® Surgical System includes two components; ORTHODOC®, a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC® Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee* replacement surgeries.

The ROBODOC® Surgical System has been cleared by the U.S. FDA for Total Hip Arthroplasty procedures; making it the only active robotic system cleared by the FDA for orthopaedic surgery. To date the system has been used in over 24,000 surgical procedures worldwide.

ROBODOC® and ORTHODOC are registered trademarks of CUREXO Technology Corporation. For more information, visit www.robodoc.com.

*Knee replacement application not for sale in the U.S.

Sacramento, CA – January 15, 2009 – CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, which is focused on marketing its ROBODOC® Surgical System, announced the addition of Brent D. Mittelstadt to its senior management team as President and Chief Executive Officer.

Mr. Mittelstadt began research in surgical robotics in 1986 as a visiting research scientist at the IBM T.J. Watson Research Center and is responsible for much of the early development of CT guided robotic systems for joint replacement surgery. In 1990, with initial investment from IBM, Mr. Mittelstadt co-founded Integrated Surgical Systems (ISS) to develop a surgical robot system to assist with hip and knee replacement surgery. In 2007, ISS with the approval of its shareholders transferred all of its assets to CUREXO Technology Corporation.

While at ISS, Mr. Mittelstadt served as Director of Surgical Applications, where he led the development and refinement of both the early pin based hip application, as well as the DigiMatch™ ROBODOC® Surgical System for Total Hip Arthroplasty (THA), which received U.S. Food and Drug Administration (FDA) clearance in August, 2008.

After leaving ISS in June 2002, Mr. Mittelstadt took a position at Consensus Orthopedics (formerly Hayes Medical Inc.), where he was Director of Marketing. Mr. Mittelstadt was part of a “turn around” management team that was integral in transforming the company. When Mr. Mittelstadt first jointed Consensus Orthopedics, it was suffering from declining sales and a poor reputation in the market. Today, Consensus Orthopedics is achieving over 60% annual growth in revenue. While at Consensus Orthopedics, Mr. Mittelstadt was involved in the development of new implants and line extensions as well as re-designing the total knee instrumentation system to address changes in the joint replacement market.

Mr. Mittelstadt received a B.S. in Biology from the University of Arizona in 1984. He holds 8 patents and has published extensively in the field of Computer Assisted Orthopedic Surgery.

“We are very excited to have Mr. Mittelstadt as a member of our senior management team. The unique combination of his ROBODOC knowledge and our recent FDA clearance provides Mr. Mittelstadt an immense opportunity to lead the company into the next phase of commercializing our products into the U.S. market. Mr. Mittelstadt brings his vast robotic experience along with integrity and vision to the company,” stated Mr. Taehoon Kim, Chairman of CUREXO Technology Corporation.

About CUREXO Technology Corporation

CUREXO Technology Corporation, develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. The ROBODOC® Surgical System includes two components; ORTHODOC®, a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC® Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee replacement surgeries.

The DigiMatch™ ROBODOC® Surgical System has been cleared by the U.S. FDA for Total Hip Arthroplasty procedures; making it the only computer-controlled robotic system cleared by the FDA for orthopedic surgery. To date the system has been used in over 24,000 surgical procedures worldwide.

ROBODOC® , ORTHODOC® , and DigiMatch™ are registered trademarks of CUREXO Technology Corporation. For more information, visit www.robodoc.com.

The DigiMatch™ ROBODOC® Surgical System, the only active robotic system cleared by the U.S. Food and Drug Administration (FDA) for orthopedic surgery, will be introduced to U.S. surgeons at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting in Dallas, November 7-9.

The system provides a precise, accurate, and repeatable surgical technique for total hip arthroplasty (THA) procedures while offering surgeons a method to preview the entire surgical plan prior to surgery, thereby minimizing human errors. Globally, it has been used in more than 24,000 joint replacement surgeries with no intraoperative fractures reported. Of these, approximately 12,000 have been THAs. Additionally, clinical data shows significant benefits using the system, including decreased risk of pulmonary embolic events, improvement in leg length, and less blood loss.

“The ROBODOC System enables orthopedic surgeons to perform more accurate procedures that are less traumatic for patients and more precise than manual preparation techniques, resulting in fewer complications,” said Dr. William Bargar, an assistant clinical professor in the Department of Orthopedic Surgery at the University of California Davis School of Medicine. “Because of these advantages, I expect this approach to become widely adopted over the next decade.”

Prior to surgery, the surgeon reviews a detailed CT scan of the patient’s joint on the system’s ORTHODOC® Preoperative Planning Workstation. Using proprietary software, the surgeon selects an ideal implant from various implant manufacturers and simulates the surgery in a virtual 3-D environment. In the operating room, the presurgical plan is transferred to the ROBODOC® Surgical Assistant, and through controlled gentle pressure, the robot precisely implements the plan with submillimeter accuracy, allowing for better than 95 percent bone contact.

“The ROBODOC System is a true innovation for orthopedic surgical applications. Surgeons now have a means for simulating surgery before it is performed, minimizing human errors, eliminating outliers and allowing deterministic outcomes,” said Dr. Ramesh Trivedi, President and CEO, ROBODOC®, a CUREXO Technology Company. “We are very pleased to offer this advanced technology to American physicians, hospitals and patients.”

ROBODOC is a gold sponsor of this year’s AAHKS conference at the Hyatt Regency DFW. To learn more about the ROBODOC System, please visit the company at booth number 198-200, or contact Eric Herrera at 713-862-2505, ext. 23, to schedule a personal meeting.

About ROBODOC

ROBODOC®, a CUREXO Technology Company, develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. This system includes two components; ORTHODOC®, a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC® Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee replacement surgeries. The ROBODOC System, previously marketed by Integrated Surgical Systems (ISS), made medical history in 1992 as the first robot assisting in a human Total Hip Arthroplasty (THA).

ROBODOC® and ORTHODOC® are registered trademarks of Curexo Technology Corporation. For more information contact press@robodoc.com

Sacramento, CA – August 13, 2008 – ROBODOC®, a CUREXO Technology Company, the pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, announced today that under the name of its predecessor, Integrated Surgical Systems, Inc., it received 510(k) clearance from the United States Food and Drug Administration (FDA) for its DigiMatch™ ROBODOC® Surgical System.

The newly cleared system delivers a precise, repeatable surgical technique to prepare the joint for hip replacement procedures. The process allows the surgeon to select an ideal implant from multiple implant manufacturers after reviewing a detailed CT scan of the patient’s joint. Utilizing the proprietary system software, surgeons for the first time can now preview the surgical outcome before beginning the actual operation.

The robotic assistant has been used in over 24,000 joint replacement procedures worldwide and is shown to be less traumatic for patients and more precise than manual preparation techniques. In Total Hip surgery applications the ROBODOC System executes exact bone cutting and precise implant placement to reduce surgical fractures and complications and minimize human error.

“We are very pleased to receive FDA clearance for the ROBODOC System. This milestone represents the first active robotic system cleared by the FDA for orthopaedic surgery allowing our advanced technology to be marketed in US, the largest market in the world for medical devices,” commented Dr. Ramesh Trivedi, President and CEO of ROBODOC. “We will continue our efforts to further penetrate existing markets where we have met the local regulatory requirements. At the same time we are building an infrastructure to introduce the ROBODOC system to U.S. orthopaedic surgeons, hospitals, and patients.”

In 2007, Integrated Surgical Systems with the approval of its shareholders transferred all of its assets to Curexo, Inc. Since the formal clinical studies were started prior to the asset transfer, 510(k) clearance has been received under the name of Integrated Surgical Systems. ROBODOC, a CUREXO Technology Company is making appropriate changes in the registration of the device with U.S. FDA.

About ROBODOC

ROBODOC®, a CUREXO Technology Company, develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. This system includes two components; ORTHODOC®, a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC® Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee replacement surgeries. The ROBODOC System, previously marketed by Integrated Surgical Systems (ISS), made medical history in 1992 as the first robot assisting in a human Total Hip Arthroplasty (THA).

ROBODOC® and ORTHODOC® are registered trademarks of Curexo Technology Corporation. For more information contact press@robodoc.com

SACRAMENTO, Calif., April 21, 2008 – ROBODOC, a Curexo Technology Company, and newly formed division of Curexo, Inc., announced today that Dr. Nobuhiko Sugano, Associate Professor, Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, will be the keynote speaker at the upcoming Indian Society of Hip and Knee Surgeons Conference (ISHKS) being held at the Taj Coromandel in Chennai, India, April 26th and 27th. Dr. Sugano will present his many years of experience in both the clinical studies and routine use of the ROBODOC System for joint replacement procedures, and refer to his multiple papers on the efficacy and safety of this technology.

"We are enthusiastic that the ISHKS has invited Dr. Sugano to speak about his experience using the ROBODOC System and pleased to sponsor him in this endeavor. This venue allows a unique opportunity to introduce and present the advantages of the Image Directed Robotics technology to the Joint Replacement surgeons of the Indian orthopaedic community," said Dr. Ramesh Trivedi, President and CEO. "Additionally, I look forward to meeting the surgeons at our exhibit and further discussing our technology," he continued.

"I am honored to be the keynote speaker for the ISHKS conference and believe my clinical insight of the ROBODOC technology will offer Indian surgeons a new platform to overcome some of the challenges in orthopaedic surgery," commented Dr. Nobuhiko Sugano. "I will also be available throughout the conference to respond to any questions from the ISHKS attendees regarding Robotics Technology in orthopaedics," he further stated.

About ROBODOC

ROBODOC, develops, manufactures, and markets a fully automated surgical robotic system for use in orthopaedic surgery. The system includes two components; ORTHODOC, a computer workstation equipped with proprietary software for preoperative surgical planning, and ROBODOC, a computer-controlled surgical robotic assistant for use in hip and knee replacement as well as other orthopaedic procedures. ROBODOC made medical history in 1992 by assisting in a Total Hip Arthroplasty (THA) procedure. Since that time, the ROBODOC system has been used in over 20,000 surgical procedures assisting surgeons around the world. The ROBODOC Surgical Assistance System is currently in its final stage of review and clearance by the FDA.

SACRAMENTO, Calif., March 3, 2008 – ROBODOC, a Curexo Technology Company, and IBM announced today that they have entered into a major patent Cross licensing agreement. The terms of the agreement were not disclosed by either party.

In addition to its current surgical robotics patents, this agreement gives ROBODOC, access to more than 40,000 patents in IBM'S Global Portfolio and particularly, IBM's surgical robotics patents.

Dan Cerutti, IBM´s general manager of intellectual property, said, "IBM enjoys a reputation of innovation and invention for technologies related to computer-assisted medicine and surgery. We are pleased to share our innovations in these areas through patent cross licenses, especially with forward-thinking companies such as ROBODOC."

"This agreement provides us with a significant improvement in our freedom of action in the Surgical Robotics and Information Management field. We intend to continue building our own intellectual property portfolio on an on-going basis" commented by Dr. Ramesh Trivedi, President and CEO of ROBODOC.

IBM has earned the most U.S. patents for 15 consecutive years. For more information on IBM, please visit www.ibm.com.

ROBODOC, a Curexo Technology Company is the United States-based subsidiary of Korea-based Curexo Inc. (KOSDAQ: XYZ). Its main research facility is in the U.S. and it reaches markets throughout the world.

About ROBODOC

ROBODOC, develops, manufactures, and markets a fully automated surgical robotic system for use in orthopaedic surgery. The system includes two components; ORTHODOC, a computer workstation equipped with proprietary software for preoperative surgical planning, and ROBODOC, a computer-controlled surgical robotic assistant for use in hip and knee replacement as well as other orthopaedic procedures. ROBODOC made medical history in 1992 by assisting in a Total Hip Arthroplasty (THA) procedure. Since that time, the ROBODOC system has been used in over 20,000 surgical procedures assisting surgeons around the world. The ROBODOC Surgical Assistance System is currently in its final stage of review and clearance by the FDA.

SACRAMENTO, Calif., February 28, 2008 – ROBODOC, a Curexo Technology Company, and newly formed division of Curexo, Inc., announced today that they will be exhibiting at the upcoming American Association of Orthopaedic Surgeons Annual Conference being held at the Moscone Center in San Francisco, March 5th through the 7th; Hall D, Booth #4470.

"Because the ROBODOC Product brand has a strong worldwide recognition, Curexo Inc. has decided to name the company ROBODOC, a Curexo Technology Company," said Dr. Ramesh Trivedi, President and CEO.

"We are looking forward to attending the AAOS meeting in San Francisco to present the only fully automated Robotics technology to the US orthopaedic community even though, it has been available for many years to the surgeons throughout the world. Combining our pioneering work with many years of experience of routinely performing joint replacement surgeries overseas and the strong support of our new partner, Curexo Inc., strongly positions us to offer a unique solution for the current and future challenges in orthopaedic surgery. Together with our partner Curexo, Inc. we have developed strong technical and marketing initiatives for the future, and are prepared to move forward into the US Market," added Dr. Trivedi.

About ROBODOC

ROBODOC, develops, manufactures, and markets a fully automated surgical robotic system for use in orthopaedic surgery. The system includes two components; ORTHODOC, a computer workstation equipped with proprietary software for preoperative surgical planning, and ROBODOC, a computer-controlled surgical robotic assistant for use in hip and knee replacement as well as other orthopaedic procedures. ROBODOC made medical history in 1992 by assisting in a Total Hip Arthroplasty (THA) procedure. Since that time, the ROBODOC system has been used in over 20,000 surgical procedures assisting surgeons around the world. The ROBODOC Surgical Assistance System is currently in its final stage of review and clearance by the FDA.